80
DAFTAR PUSTAKA
Aguwa, C.N., Ukwe, C.V., dan Ekwunife, O.I. (2007). Effect of Pharmaceutical Care Programme on Blood Pressure and Quality of Life in a Nigerian Pharmacy. Pharm World Sci. 30(1): 107-110.
Ayalon, L., Gross, R., Tabenkin, H., Porath, A., Heymann, A., dan Porter, B. (2006). Correlates of Quality of Life in Primary Care Patients With Hypertension. Int’l. J. Psychiatry in medicine.36(4): 483-497.
Badan POM. (2012). Potensi Risiko Efek Samping Kardiovaskular dan Ginjal Pada Pasien Diabetes Tipe 2 yang DiterapiDengan Aliskiren. Buletin Berita MESO. 30(2): 6.
Basuki. (1999). Besar Sampel Dalam: Metodologi Penelitian Bidang Kedokteran. Editor:Tjokronegoro, Arjatmo, Sudarsono, Sumedi. 1999. Cetakan Ketiga. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia.Hal. 135-138.
Berenguer, C., La Casa, M.J., Matta, M.J., dan Calero, M. (2004). Pharmaceutical care: Past, Present and Future. Current Pharmaceutical Design. 10: 3931-3946.
Bisharat, B., Hafi, L., Epel, O.B., Armaly, Z., dan Bowirrat, A. (2012). Pharmacist Counseling to Cardiac Patients in Israel Prior to Discharge from Hospital Contribute to Increasing Patient’s Medication Adherence Closing Gaps and Improving Outcomes. Journal of Translational Medicine. 10(34): 1-9.
Boulware, L.E., Daumit, G.L., Frick K.D., Minkovitz, C.S., Lawrence, R.S., dan Powe N.R. (2001). An Evidence-based review of Patient-centered Behavioral Interventions for Hypertension. Am J Prev Med. 21(1): 221-232.
Brouker, E.M., Gallagher, K., Larrat, E. P., dan Dufresne, R.L. (2000). Patient Compliance and Blood Pressure Control on A Nuclear-powered Aircraft Carrier: Impact of Pharmacy Officer. Military Medicine. 165(2): 106-110.
Brown, C.D., Higgins, M., Donato,K.A.,dan Rohde, F.C. (2000). Body Mass Index and the Prevalence of Hypertension and Dyslipidemia.Obese Res.8(9): 605-619.
Bunting, B.A., Smith, B.H., dan Sutherland, S.E. (2008). The Asheville Project: Clinical and Economic Outcomes of a Community-based Long-term Medication Therapy Management Program for Hypertension and Dyslipidemia. J Am Pharm Assoc. 48(1): 23-31.
81
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jones, D.W., Materson, B.J., Oparil, S., dan Wright, J.T. (2003). The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension JAMA. 289(19): 2560-2570.
Cipolle, R.J.,Strand, L.M., dan Morley, P.C. (2004). Follow-Up Evaluation. In: Pharmaceutical care Practice: The Clinician’s Guide. Edisi ke-2. New York: Mc Graw-Hill Companies. Hal. 3-7.
Depkes RI. (2003). Kebijakan dan Strategi Nasional Pencegahan dan Penanggulangan Penyakit Tidak Menular. Jakarta: Departemen Kesehatan RI. Hal. 2-8.
Depkes RI. (2005).Pharmaceutical Care Untuk Penyakit Diabetes Mellitus. Jakarta: Departemen Kesehatan RI. Hal. 59.
Depkes RI. (2006).Pharmaceutical Care Untuk Penyakit Hipertensi. Jakarta:Departemen Kesehatan RI. Hal. iii, 6, 23-26, 42-54.
Depkes RI. (2008). Riset Kesehatan Dasar (RISKESDAS) 2007. Jakarta: Departemen Kesehatan RI. Hal. 110-112.
Donald, A. (2001). What is Quality of Life?. Diakses 28 Pebruari 2012. Diambil dari
Donovan, D., Byrne, S. dan Sahm, L. (2011). The Role Of Pharmacists In Control And Management Of Type 2 Diabetes Mellitus; A Review Of The Literature. Journal of Diabetology. 1(5): 1-16.
Dosh, S.A. (2001). The Diagnosis of Essential and Secondary Hypertension in Adults.J.Fam Pract. 50(1): 707-712.
Eng,J. (2003). Sample Size Estimation: How Many Individuals should be Studied?. Statistical Concepst Series. Radiology.227(2): 309-313.
European Society of Hypertension. (2007). Guidelines for the Management of Arterial Hypertension. JournalHypertens.25(1): 85-87.
Gray, H.H., Dawkins, K.D., Morgan, J.M., dan Simpson, I.A.(2005). Kardiologi: Lecture Notes. Edisi ke-4. Jakarta: Penerbit Erlangga. Hal. 57-69.
82
Hunt, S.A., Abraham, W.T., Chin, M. H., Feldman, A.M., Francis, G.S., Ganiats, T.G., Jessup, M., Konstam, M.A. (2005). ACC/AHA Guideline Update For The Diagnosis And Management Of Chronic Heart Failure In The Adult. Journal of The American College of Cardiology and Circulation. 71(1): 0327.
Jiang, L., Beals, J., Whitesell, N.R., Roubideaux, Y., dan Manson, S.M. (2009). Health-Related Quality of Life And Help Seeking Among American Indians With Diabetes And Hypertension. Qual Life Res., 18: 709–718.
Kaplan, M.N. (1998). Measurenment of Blood Pressure and Primary Hypertension: Pathogenesis in Clinical Hypertension. Edisi ke-7. Maryland: Williams & Wilkins. Hal.1-17, 28-46.
Karodeh, Y.R., Edafiogho, I., Hailemeskel, B., Ofosu, J.R., dan Karla, P.K. (2011). Clinical Implications and Limitations of JNC7 in HTN Management and Recommendations for JNC8. Archives of Pharmacy Practice.2(3): 84-89.
Kearney, M.P., Whelton, M., Reynolds, K., Muntner, P., dan Whelton, P. (2005). Global Burden of Hypertension: Analysis of Worldwide Data. Lancet.365(1): 271-223.
Khaw, W.F., Hassan, S.T.S., dan Latiffah, A.L. (2011). Health-related Quality of Life Among Hypertensive Patients Compered with General Population Norms. J. Med. Sci.11(2): 84-89.
Khomsan, A. (2003). Pangan dan Gizi untuk Kesehatan. Jakarta: PT. Rineka Cipta.Hal. 88, 93.
Kier, L.K., Malone, M.P., dan Stanovich, J. (2007).Drug Information. A Guide for Pharmacists.Edisi ke-3. New York: Mc Graw-Hill Companies. Hal. 40-41.
Kisjanto, J. (2001). Hypertension in Indonesia, Difference in Java and the other Islands. WHF Global conference on Cardiovascular Clinical Trial. 1(1): 1.
Kumar, K.V., Abbas A.K., dan Fausto, N. (2005). Hypertensive Vascular Disease.
Dalam: Robn and Cotran Pathologic Basis of Disease. Edisi ke-7. Philadelpia:
Elsevier Saunders. Hal. 528-529.
Kusniyah, Y., Nursiswati, dan Rahayu, U. (2010). Hubungan Terkait Self Care dengan Tingkat HbA1c pada Klien Diabetes Melitus Tipe 2 di Poliklinik
Endokrin RSUP dr. Hasan Sadikin Bandung. Artikel Self Care., Hal. 17-20.
83
Morgado, M., Rolo, S., dan Branco, C.M. (2011). Pharmacist Intervention Program to Enhance Hypertension Control: A Randomised Controlled Trial. Int J Clin Pharm.33: 132-140.
Muenster, V.S.J., Carter, B.L., Weber, C.A., Ernst, M.E., dan Steffensmeier, J.J.G. (2007). Description of Pharmacist Interventions During Physician-Pharmacist Co-management of Hypertension. Pharm World Sci. 30: 128-135.
Oparil, S., Zaman, A., dan Calhoun, D.A.(2003). Pathogenesis of Hypertension. AnnInternal Medicine. 139: 761-776.
Piepho, R.W. (2000). Overview The Angiotensin-Converting-Enzyme-Inhibitor. Am J Health- Syst Pharm.57(1): 3-7.
Poljičanin, T., Ajduković, D., Šekerija, M., Okanović, M.P., Metelko, Z., danMavrinac, G.P. (2010). DiabetesMellitus and Hypertension have Comparable Adverse Effects on Health-related Quality of Life. BMC Public Health. 10(12): 1-6.
Rahajeng, E., dan Tuminah, S. (2009). Prevalensi Hipertensi dan Determinannya di Indonesia. Pusat Penelitian Biomedis dan Farmasi Badan Penelitian Kesehatan Departemen Kesehatan RI.Majalah Kedokteran Indonesia. 59(12): 581.
Rantucci, M.J. (2007). Pharmacists Talking With Patients: A Guide To Patient Counseling. Edisi ke-2. Philadelphia: Lippincott William & Wilkins.Hal. 15-18.
Safrian. (2012). Hubungan Antara Subjective Global Assessment Dengan Kualitas Hidup Dan Phase Angle Pada Bioelectrical Impedance Analysis Pada Pasien Limfoma Non Hodgkin. Tesis. Medan:Fakultas Kedokteran USU.
Saseen, J. J., dan Carter, B. L. (2005). Hypertension. Dalam: PharmacotherapyA Pathophysiologic Aproach. Editor: Joseph T. Dipiro, Robert L. Talbert,Gary C. Yee, Gary R. Matzke, dan Barbara G. Wells. Edisi ke-6. New York: The McGraw-Hill Companies, Inc. Hal.185-214.
Shah, S.V., Anjum, S., dan Littler, W.A. (2004). Use of Diuretics in Cardiovascular Disease: (2) Hypertension. PostgradMed J. 80(1): 271-276.
84
Sunarto, A.A. (2007). Ancaman Serius Hipertensi di Indonesia. Jurnal Farmacia. 6(7):34 [diakses 23 Januari 2012]. Diambil dari:
Theodosha, S.G., Lackland, B.E., dan Robert, W. (2000).Effect of Total Obesity and Abdominal Obesity on Hypertension.Charleston: Medical University of Saouth Caroline. Hal. 123.
Wahyuni, S.A. (2011). Statistika Kedokteran. Jakarta: Bamboedoea Communication. Hal. 114-115.
Ware, J.E. (2000). SF-36 Health Survey Update.SPINE. 25(24): 3130-3139.
Wick, J.Y. (2011). Chronic Kidney Disease: Pharmacist Intervention Can Improve Quality of Life. Pharmacy Times. 2(9): 1 [diakses 31 Maret 2013]. Diambil dari:
Wiryana, M. (2008). Manajemen Perioperatif Pada Hipertensi. Bagian/SMF Ilmu Anestesi dan Reanimasi FK Unud/RSUP Sanglah Denpasar. Jurnal Penyakit Dalam.9(2): 145.
WHO. (1994). Department of Psychiatry Centre for Participant Report Outcomes.Diakses 21 Pebruari 2012.Diambil dari:
WHO. (2001).Pengendalian Hipertensi. Alih Bahasa: Prof. Dr. Kosasih Padmawinata. Bandung: Penerbit ITB.Hal. 14, 50-51.
WHO. (2003). International Society of Hypertension Statement on Management of Hypertension.J Hypertens. 2(1):1983-1992.
Wolz, M. (2000). National Health and Nutrition Examination Survey (NHANES). National Heart, Lung and Blood Institute. 1(1):1
Renin Angiotensin System. Diakses 24 Januari 2013.
Yogiantoro, M.(2006). Hipertensi Esensial. Dalam:Buku Ajar Ilmu Penyakit Dalam. Editor: Aru Sudoyo, Bambang Setiyohadi, Idrus Alwi, Marcellus Simadibrata, dan Siti Setiati. Edisi 4. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FK UI.Hal. 599-603.
Zadeh, K.K.(2000). SF-36 Quetionaire’ User Manual Format Modified.J Am Soc Neph. 13(1): 396-340.
